Skip to main content

Zomedica Corp.

ZOMDF
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001684144

No open-market purchases or sales by Zomedica Corp. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $9.50K in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Zomedica Corp. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of ZOMDF: Q3 2022 compared with Q4 2022
MeasureQ3 2022Of which not filed for Q4 2022Q4 2022Change
Holders88192+5
Shares92.4M4.00K93.5M+1.09M (+1.2%)
Value$19.5M$1.00K$15.3M−$4.24M (−21.7%)

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (13)

Institutions that held Zomedica Corp. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to ZOMDF in Q4 2022
InstitutionSharesValue% of portfolio
Money Concepts Capital Corp152,341$24.8K0.00%
West Michigan Advisors, LLC100,000$16.3K0.01%
Creative Planning44,100$7.19K0.00%
Glass Jacobson Investment Advisors llc42,800$6.98K0.00%
GWM Advisors LLC20,500$3.34K0.00%
Cetera Investment Advisers18,600$3.03K0.00%
Strategies Wealth Advisors, LLC12,500$2.04K0.00%
National Asset Management, Inc.10,000$1.63K0.00%
U.S. Capital Wealth Advisors, LLC6,055$9870.00%
Hexagon Capital Partners LLC283$460.00%
The PNC Financial Services Group, Inc.200$320.00%
CarsonAllaria Wealth Management, Ltd.20$00.00%
Strengthening Families & Communities, LLC9$00.00%

Sold out (8)

Institutions that held Zomedica Corp. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of ZOMDF in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Charles Schwab Investment Management Inc343,967$73.0K
Susquehanna International Group, LLP220,286$46.0K
UBS Group AG210,693$44.0K
Millennium Management LLC159,009$34.0K
Beacon Pointe Advisors, LLC81,911$17.0K
Citadel Advisors LLC15,705$3.00K
Raymond James Financial Services Advisors, Inc.15,915$3.00K
Evoke Wealth, LLC33$0

Not filed for Q4 2022 yet (1)

Institutions that held Zomedica Corp. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ZOMDF in Q3 2022 that haven't filed for Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
FourThought Financial, LLC4,000$1.00K